News | November 23, 2024
Merck recommends rejection of TRC Capital’s “Mini-Tender” Offer
The offer price is approximately 4.32% below the closing price of the Merck common stock on November 11, 2024
The offer price is approximately 4.32% below the closing price of the Merck common stock on November 11, 2024
Octreotide is synthetic peptide manufactured by Shilpa Pharma Lifesciences through solid phase synthesis
This is used to treat central diabetes insipidus and bedwetting
The observations are of procedural in nature and will be responded to within the stipulated time
The raised capital enables Medix Biochemica to continue execution of inorganic growth initiatives
The USFDA inspection focused on evaluating the facility's adherence to global regulatory requirements and best practices
The Dengue IgG/IgM Rapid Test is a diagnostic tool used to detect antibodies against the dengue virus in blood samples
These accolades highlight our unwavering commitment to maintaining the highest safety standards
This is in partnership with Mepro Pharmaceuticals which have successfully developed and commercialised the Albendazole Chewable formulation
He recently served as Senior Vice President of the API business at Shilpa Pharma Life Sciences for over 3 years
Subscribe To Our Newsletter & Stay Updated
